Evidence map›Paper›PMID 27293431›Full record

ArticleAdvances in bioinformatics2016

A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data.

Manuel Galli, Italo Zoppis, Gabriele De Sio, Clizia Chinello, Fabio Pagni, Fulvio Magni, Giancarlo Mauri

Abstract read
In one paragraph

Article in Advances in bioinformatics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manuel GalliDepartment of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza Brianza, Italy.ORCID 0000-0003-4862-9599
Italo ZoppisDepartment of Informatics, Systems and Communication, University of Milano-Bicocca, Viale Sarca 336, 20125 Milan, Italy.ORCID 0000-0001-7312-7123
Gabriele De SioDepartment of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza Brianza, Italy.
Clizia ChinelloDepartment of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza Brianza, Italy.
Fabio PagniDepartment of Surgery and Translational Medicine, Section of Pathology, University of Milano-Bicocca, Milan, Italy.
Fulvio MagniDepartment of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza Brianza, Italy.ORCID 0000-0002-8663-0374
Giancarlo MauriDepartment of Informatics, Systems and Communication, University of Milano-Bicocca, Viale Sarca 336, 20125 Milan, Italy.ORCID 0000-0003-3520-4022

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomarkers able to characterise and predict multifactorial diseases are still one of the most important targets for all the "omics" investigations. In this context, Matrix-Assisted Laser Desorption/Ionisation-Mass Spectrometry Imaging (MALDI-MSI) has gained considerable attention in recent years, but it also led to a huge amount of complex data to be elaborated and interpreted. For this reason, computational and machine learning procedures for biomarker discovery are important tools to consider, both to reduce data dimension and to provide predictive markers for specific diseases. For instance, the availability of protein and genetic markers to support thyroid lesion diagnoses would impact deeply on society due to the high presence of undetermined reports (THY3) that are generally treated as malignant patients. In this paper we show how an accurate classification of thyroid bioptic specimens can be obtained through the application of a state-of-the-art machine learning approach (i.e., Support Vector Machines) on MALDI-MSI data, together with a particular wrapper feature selection algorithm (i.e., recursive feature elimination). The model is able to provide an accurate discriminatory capability using only 20 out of 144 features, resulting in an increase of the model performances, reliability, and computational efficiency. Finally, tissue areas rather than average proteomic profiles are classified, highlighting potential discriminating areas of clinical interest.

Identifiers

PMID27293431
PMCPMC4886047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.